Ribero, D., Wang, H., Donadon, M., Zorzi, D., Thomas, M. B., Eng, C., . . . Vauthey, N. (2007). Bevacizumab Improves Pathologic Response and Protects Against Hepatic Injury in Patients Treated With Oxaliplatin-Based Chemotherapy for Colorectal Liver Metastases.
Chicago Style (17th ed.) CitationRibero, David, et al. Bevacizumab Improves Pathologic Response and Protects Against Hepatic Injury in Patients Treated With Oxaliplatin-Based Chemotherapy for Colorectal Liver Metastases. 2007.
MLA (9th ed.) CitationRibero, David, et al. Bevacizumab Improves Pathologic Response and Protects Against Hepatic Injury in Patients Treated With Oxaliplatin-Based Chemotherapy for Colorectal Liver Metastases. 2007.
Warning: These citations may not always be 100% accurate.